P.384 Phase 1 study of intra-arterial hepatic (IAH) delivery of doxorubicin-transdrug® (DT) for patients with advanced hepatocellular carcinoma (HCC)Philippe Merle, C. Trépo, Julien Taı̈eb et al.|Journal of Clinical Virology|2006Cited by 19
Phase 1 study of intra-arterial hepatic (IAH) delivery of doxorubicin-transdrug (DT) for patients with advanced hepatocellular carcinoma (HCC)Philippe Merle, Christian Trépo, Shahid Ahmed et al.|Journal of Clinical Oncology|2006Cited by 18